Medistim ASA (STO:MEDIO)

Market Cap	4.35B
Revenue (ttm)	624.70M
Net Income (ttm)	134.36M
Shares Out	n/a
EPS (ttm)	7.35
PE Ratio	32.34
Forward PE	28.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24
Average Volume	212
Open	259.00
Previous Close	259.00
Day's Range	259.00 - 259.00
52-Week Range	144.00 - 284.00
Beta	n/a
RSI	55.86
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK